↑ Abou-Alfa,GK;Letourneau,R;Harker,G;Modiano,M;Hurwitz,H;Tchekmedyian,NS;Feit,K;Ackerman,Jet al.(20 September 2006).“Randomized Phase III Study of Exatecan and Gemcitabine Compared with Gemcitabine Alone in Untreated Advanced Pancreatic Cancer”.Journal of Clinical Oncology24(27): 4441–7.doi:10.1200/JCO.2006.07.0201.PMID16983112.